Skip to main content

Table 2 Concentrations of plasma lysophospholipids in the subgroups of chronic kidney disease patients and the control group

From: Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy

Parameter

Subgroup

CT

HD

PD

RT

Con

P*

D1

D2

D1

D2

LPA [μM]

Mean ± SD

1.61 ± 1.35

0.99 ± 0.78

1.41 ± 1.75

2.43 ± 1.99

1.31 ± 1.02

2.12 ± 1.33

0.96 ± 0.58

< 0.001

Median

1.28

0.94

0.80

1.96

0.89

1.74

0.82

LPC [μM]

Mean ± SD

6.29 ±3.24

5.69 ±3,34

6.74 ±3.89

7.52 ±3.37

7.01 ±3.87

7.00 ±3.48

9.06 ±4.02

< 0.001

Median

5.61

5.12

5.82

6.46

5.98

6.65

8.51

  1. *p value for differences between CT, HD D1, HD D2, PD, RT D1, RT D2 and Con in Kruskal-Wallis test;
  2. LPA – lysophosphatidic acid, LPC – lysophosphatidylcholine, CT –patients treated conservatively, HD D1–patients on hemodialysis before the dialysis (1st donation), HD D1–patients on hemodialysis after the dialysis (2nd donation), PD –patients on peritoneal dialysis, RT D1– renal transplant recipients before the transplantation (1st donation), RT D2– renal transplant recipients after the transplantation (2nd donation), Con – control group, W – women, M – men, SD – standard deviation
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X